{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:32:57Z","timestamp":1787020377460,"version":"build-2736575974"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003669","name":"Korea Centers for Disease Control and Prevention","doi-asserted-by":"crossref","award":["2017N-ER5405-01"],"award-info":[{"award-number":["2017N-ER5405-01"]}],"id":[{"id":"10.13039\/501100003669","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Fluoroquinolone agents, such as enrofloxacin and marbofloxacin, are commonly used for pseudomonal infection in veterinary medicine. However, the rate of resistance to fluoroquinolones is rapidly increasing, according to multiple studies in various countries. Point mutations in the quinolone resistance-determining region (QRDR) are closely related to the increased fluoroquinolone resistance of\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      . The aim of this study was to investigate current antimicrobial susceptibility and fluoroquinolone resistance in\n                      <jats:italic>P. aeruginosa<\/jats:italic>\n                      strains isolated from dogs. The presence of point mutations in the QRDR was confirmed by\n                      <jats:italic>gyrA<\/jats:italic>\n                      and\n                      <jats:italic>parC<\/jats:italic>\n                      polymerase chain reaction and nucleotide sequencing analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 84 nonduplicated\n                      <jats:italic>P. aeruginosa<\/jats:italic>\n                      strains were obtained from 228 healthy dogs (healthy group) and 260 dogs with clinical signs (infected group). Among these isolates, 38 strains from the healthy group were detected in several sample types, whereas 46 strains from the infected group were obtained mostly from dogs\u2019 ears with otitis externa (41\/260, 15.8%). All strains were resistant to nalidixic acid, while some were also resistant to enrofloxacin (23\/84, 27.4%), marbofloxacin (17\/84, 20.2%), levofloxacin (12\/84, 14.3%), or ciprofloxacin (11\/84, 13.1%). Enrofloxacin resistance was significantly higher in strains from the infected group than in those from the healthy group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Among the 23 fluoroquinolone-resistant strains, 8 and 4 different mutations were detected in the\n                      <jats:italic>gyrA<\/jats:italic>\n                      and\n                      <jats:italic>parC<\/jats:italic>\n                      genes, respectively. Mutations in\n                      <jats:italic>gyrA<\/jats:italic>\n                      were significantly common in the infected group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Hotspots for the\n                      <jats:italic>gyrA<\/jats:italic>\n                      and\n                      <jats:italic>parC<\/jats:italic>\n                      mutations were Thr83 (34.8%, 8\/23) and Pro116 (91.3%, 21\/23), respectively. Double and triple mutations were also found in 5 of the strains.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Novel mutations in the\n                      <jats:italic>gyrA<\/jats:italic>\n                      and\n                      <jats:italic>parC<\/jats:italic>\n                      genes were first found in\n                      <jats:italic>P. aeruginosa<\/jats:italic>\n                      isolated from companion dogs in South Korea. These findings suggest that it is important to encourage prudent use of fluoroquinolone antibiotics in canine pseudomonal infection treatment.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12917-020-02328-0","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T06:03:05Z","timestamp":1586930585000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Antimicrobial resistance and novel mutations detected in the gyrA and parC genes of Pseudomonas aeruginosa strains isolated from companion dogs"],"prefix":"10.1186","volume":"16","author":[{"given":"Youjin","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeyoung","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sowon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuth","family":"Sum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonkeun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongchan","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heemyung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,15]]},"reference":[{"key":"2328_CR1","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/jac\/dkh325","volume":"54","author":"K K\u0171mmerer","year":"2004","unstructured":"K\u0171mmerer K. Resistance in the environment. J Antimicrob Chemother. 2004;54:311\u201320.","journal-title":"J Antimicrob Chemother"},{"key":"2328_CR2","doi-asserted-by":"crossref","unstructured":"Hammerum AM, Heuer OE. Human health hazards from antimicrobial-resistant Escherichia coli of animal origin. Clin Infect Dis. 2009;48:916\u201321.","DOI":"10.1086\/597292"},{"key":"2328_CR3","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3390\/ijerph10010278","volume":"10","author":"PM Costa","year":"2013","unstructured":"Costa PM, Loureiro L, Matos AJ. Transfer of multidrug resistant bacteria between intermingled ecological niches: the interface between humans, animals and the environment. Int J Environ Res Public Health. 2013;10:278\u201394.","journal-title":"Int J Environ Res Public Health"},{"key":"2328_CR4","unstructured":"European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2014. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2015."},{"key":"2328_CR5","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.ijantimicag.2004.09.004","volume":"24","author":"D Meunier","year":"2004","unstructured":"Meunier D, Acar JF, Martel JL, Kroemer S, Valle M. 2004. A seven-year survey of susceptibility to marbofloxacin of pathogenic strains isolated from pets. Int J Antimicrob Agents. 2004;24:592\u20138.","journal-title":"Int J Antimicrob Agents"},{"key":"2328_CR6","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.vetmic.2008.02.018","volume":"131","author":"J Rubin","year":"2008","unstructured":"Rubin J, Walker RD, Blickenstaff K, Bodeis-Jones S, Zhao S. Antimicrobial resistance and genetic characterization of fluoroquinolone resistance of Pseudomonas aeruginosa isolated from canine infections. Vet Microbiol. 2008;131:164\u201372.","journal-title":"Vet Microbiol"},{"key":"2328_CR7","doi-asserted-by":"crossref","unstructured":"Harada K, Arima S, Nina A, Kataoka Y, Takahashi T. Characterization of Pseudomonas aeruginosa isolates from dogs and cats in Japan: current status of antimicrobial resistance and prevailing resistance mechanisms. Microbiol Immunol. 2012;56:123\u20137.","DOI":"10.1111\/j.1348-0421.2011.00416.x"},{"key":"2328_CR8","doi-asserted-by":"crossref","unstructured":"Arais LR, Barbosa AV, Carvalho CA, Cerqueira AM. Antimicrobial resistance, integron carriage, and gyrA and gyrB mutations in Pseudomonas aeruginosa isolated from dogs with otitis externa and pyoderma in Brazil. Vet Dermatol. 2016;27:113\u20137e31.","DOI":"10.1111\/vde.12290"},{"key":"2328_CR9","doi-asserted-by":"crossref","unstructured":"Pintari\u0107 S, Matanovi\u0107 K, Martinec BS. Fluoroquinolone susceptibility in Pseudomonas aeruginosa isolates from dogs-comparing disk diffusion and microdilution methods. Veterinarski Arhiv. 2017;87:291\u2013300.","DOI":"10.24099\/vet.arhiv.160120"},{"key":"2328_CR10","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.diagmicrobio.2014.03.025","volume":"79","author":"X Jiang","year":"2014","unstructured":"Jiang X, Yu T, Jiang X, Zhang W, Zhan L, Ma J. Emergence of plasmid-mediated quinolone resistance genes in clinical isolates of Acinetobacter baumannii and Pseudomonas aeruginosa in Henan. China Diagn Microbiol Infect Dis. 2014;79:381\u20133.","journal-title":"China Diagn Microbiol Infect Dis"},{"key":"2328_CR11","doi-asserted-by":"crossref","unstructured":"Seol B, Nagli\u0107 T, Madi\u0107 J, Bedekovi\u0107 M. In vitro antimicrobial susceptibility of 183 Pseudomonas aeruginos a strains isolated from dogs to selected antipseudomonal agents. J Vet Med B Infect Dis Vet Public Health. 2002;49:188\u201392.","DOI":"10.1046\/j.1439-0450.2002.00548.x"},{"key":"2328_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.5326\/0430337","volume":"43","author":"BE Wildermuth","year":"2007","unstructured":"Wildermuth BE, Griffin CE, Rosenkrantz WS, Boord MJ. Susceptibility of Pseudomonasisolates from the ears and skin of dogs to enrofloxacin, marbofloxacin, and ciprofloxacin. J Am Anim Hosp Assoc. 2007;43:337\u201341.","journal-title":"J Am Anim Hosp Assoc"},{"key":"2328_CR13","doi-asserted-by":"crossref","unstructured":"McKay L, Rose CD, Matousek JL, Schmeitzel LS, Gibson NM, Gaskin JM. Antimicrobial testing of selected fluoroquinolones against Pseudomonas aeruginosa isolated from canine otitis. J Am Animal Hosp Assoc. 2007;43:307\u201312.","DOI":"10.5326\/0430307"},{"key":"2328_CR14","doi-asserted-by":"crossref","unstructured":"Meki\u0107 S, Matanovi\u0107 K, \u0160eol B. Antimicrobial susceptibility of Pseudomonas aeruginosa isolates from dogs with otitis externa. Vet Rec. 2011;169:125.","DOI":"10.1136\/vr.d2393"},{"key":"2328_CR15","first-page":"242","volume":"10","author":"RM Farahi","year":"2018","unstructured":"Farahi RM, Ali AA, Gharavi S. Characterization of gyrA and parC mutations in ciprofloxacin-resistant Pseudomonas aeruginosa isolates from Tehran hospitals in Iran. Iran J Microbiol. 2018;10:242\u20139.","journal-title":"Iran J Microbiol"},{"key":"2328_CR16","unstructured":"CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 27th ed. CLSI supplement M100. Wayne: Clinical and Laboratory Standards Institute; 2017.\u00a0."}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-020-02328-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-020-02328-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-020-02328-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T19:40:00Z","timestamp":1618429200000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-020-02328-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,15]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2328"],"URL":"https:\/\/doi.org\/10.1186\/s12917-020-02328-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.13226\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.13226\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.13226\/v5","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.13226\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.13226\/v2","asserted-by":"object"}]},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,15]]},"assertion":[{"value":"11 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All samples collected from companion animals were collected under the owner\u2019s approval in written consent. Every individual was provided with a document explaining the purpose and method of sample collection. Furthermore, ethics approval was waivered by Institutional Review Board under [Exempt review categories of research] (Korean Council of Science Editors,\n                      \n                      ).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors have any other financial or personal relationships that could inappropriately influence or bias the content of the paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"111"}}